Inventor · disambiguated record
Harald Zilch
Also filed as: ZILCH HARALD
21 granted patents·1 pending application·575 citations·filing 1989–2002
95Inventor score
Top patents by PatentIndex Score
22 records- 0196US5414088A2-bicyclobenzimidazoles, processes for their preparation and medicaments containing these compoundsBOEHRINGER MANNHEIM GMBH·Filed 1990·Granted May 9, 1995·121 cites·13 claims
- 0294US5563257APhospholipid derivatives of nucleosidesBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted Oct 8, 1996·91 cites·18 claims
- 0390US5002937ADiphosphonic acid compounds and use for calcium metabolism disordersBOEHRINGER MANNHEIM GMBH·Filed 1989·Granted Mar 26, 1991·56 cites·8 claims
- 0487US5756711APhospholipid derivatives of nucleosides and their use as anti-viral medicamentsBOEHRINGER MANNHEIM GMBH·Filed 1996·Granted May 26, 1998·106 cites·11 claims
- 0584US5135949APharmaceutical compositions containing phenylamidesBOEHRINGER MANNHEIM GMBH·Filed 1989·Granted Aug 4, 1992·38 cites·18 claims
- 0679US5446139APurine analog nucleoside and nucleotide compoundsBOEHRINGER MANNHEIM GMBH·Filed 1990·Granted Aug 29, 1995·54 cites·12 claims
- 0776US4985448AUreidoindoles, pharmaceutical compositions and methods for erythrocyte and thrombocyte aggregation inhibitionBOEHRINGER MANNHEIM GMBH·Filed 1989·Granted Jan 15, 1991·19 cites·15 claims
- 0873US5512564ATricyclic thiazole and oxazole derivatives and pharmaceutical agents containing themBOEHRINGER MANNHEIM GMBH·Filed 1992·Granted Apr 30, 1996·14 cites·19 claims
- 0968US6372725B1Specific lipid conjugates to nucleoside diphosphates and their use as drugsFiled 1998·Granted Apr 16, 2002·24 cites·6 claims
- 1060US5373019APharmaceutical lactam compositions for inhibition of erythrocyte and thrombocyte aggregationBOEHRINGER MANNHEIM GMBH·Filed 1991·Granted Dec 13, 1994·13 cites·8 claims
- 1155US6136797APhospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicamentsFiled 1996·Granted Oct 24, 2000·14 cites·8 claims
- 1249US7176011B2Lipid cleavage enzymeHEIDELBERG PHARMA AG·Filed 2002·Granted Feb 13, 2007·0 cites·16 claims
- 1348US6025343ALipid esters of nucleoside monophosphates and their use as immunosuppressive drugsROCHE DIAGNOSTICS GMBH·Filed 1996·Granted Feb 15, 2000·8 cites·25 claims
- 1446US6177469B1Lipid alcohols as new immunosuppressive and antiviral drugsFiled 1996·Granted Jan 23, 2001·7 cites·19 claims
- 1542US5158942AProcess of using phospholipid derivatives to inhibit multiplication of the human immunodeficiency virusBOEHRINGER MANNHEIM GMBH·Filed 1990·Granted Oct 27, 1992·3 cites·8 claims
- 1641US6080734ALiponucleotides of seco-nucleosides, their production as well as their use as antiviral pharmaceutical agentsROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Jun 27, 2000·2 cites·11 claims
- 1737US5955452ACovalent lipid-phosphono-carboxylic acid conjugates and application thereof as antiviral medicamentsROCHE DIAGNOSTICS GMBH·Filed 1996·Granted Sep 21, 1999·3 cites·16 claims
- 1833US5543561AAcyclic amidine group-containing diphosphonic acid derivatives, processes for their preparation and medicaments containing these compoundsBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Aug 6, 1996·1 cites·12 claims
- 1933US5366969AAmidine group containing monocycloheteracyclic or bicycloheterocyclic diphosphonic acid derivatives and medicaments containing these compoundsBOEHRINGER MANNHEIM GMBH·Filed 1992·Granted Nov 22, 1994·1 cites·9 claims
- 2031US2002106363A1Lipid cleavage enzymeFiled 1999·Application pending·0 cites
- 2128US5397794AUse of thiazoloisoindolinone derivatives as antiviral medicamentsBOEHRINGER MANNHEIM GMBH·Filed 1991·Granted Mar 14, 1995·0 cites·5 claims
- 2219US5734042AProcess for the production of asymmetrical phosphoric acid diestersBOEHRINGER MANNHEIM GMBH·Filed 1995·Granted Mar 31, 1998·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Harald Zilch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →